Mechanisms of Drug Desensitization: Not Only Mast Cells
Drug desensitization (DD) allows transient clinical tolerance to the drug in reactive patients and it is frequently and successfully used in the management of both IgE and non IgE-mediated hypersensitivity reactions (HRs). The underlying mechanisms behind this process is not well understood. The des...
Main Authors: | Alessandra Vultaggio, Andrea Matucci, Francesca Nencini, Susanna Bormioli, Emanuele Vivarelli, Enrico Maggi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.590991/full |
Similar Items
-
IL-10 in Mast Cell-Mediated Immune Responses: Anti-Inflammatory and Proinflammatory Roles
by: Kazuki Nagata, et al.
Published: (2021-05-01) -
PENGARUH EKSTRAK KULIT BUAH NAGA MERAH (HYLOCEREUS POLYRHIZUZ) DALAM MENGHAMBAT DEGRANULASI SEL MAST DAN MENCIT PUTIH JANTAN YANG TERSENSITISASI AKTIF
by: Relin Yesika, et al.
Published: (2023-03-01) -
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
by: Jan Romantowski, et al.
Published: (2021-02-01) -
Mast cells & Company
by: Friederike eJönsson, et al.
Published: (2012-02-01) -
T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis
by: Sara Pratesi, et al.
Published: (2019-01-01)